Work

Adjusted RECIST Criteria for Assessing Time to Recurrence in Patients with Fully Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Year: 2024

Type: article

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2024.01.039

Authors: S.P. Eggleton, M. O'Neal, R. Ford, A. Schroeder, M. Bajars, C. Le Tourneau, R.L. Ferris

Institutions: Merck KGaA, Darmstadt (Germany), Merck Serono Ltd. (United Kingdom), BioClinica (United States), Merck Healthcare KGaA, Darmstadt (Germany), Institut Curie, University of Pittsburgh Medical Center

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4392824431

FWCI:

Cites:

Cited by:

Related to: 10